Legend Biotech (LEGN) Cash from Operations (2019 - 2025)
Legend Biotech (LEGN) posted Cash from Operations of 12200000.0 for Q4 2025, down 142.36% on a QoQ basis from 28801000.0 in Q3 2025, and up 85.14% year-over-year from 6589605.26 in Q4 2024.
Legend Biotech (LEGN) Cash from Operations (2019 - 2025) Analysis & Trends
Legend Biotech's Cash from Operations history runs 7 years deep, the most recent figure standing at 12200000.0 for Q4 2025.
- Quarterly Cash from Operations rose 85.14% year-over-year to 12200000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 100195000.0 (up 30.45% YoY) and the FY2025 annual result came in at 100200000.0, up 30.42% from the prior year.
- Cash from Operations was 12200000.0 for Q4 2025 at Legend Biotech, down from 28801000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 28801000.0 in Q3 2025 and bottomed at 198465000.0 in Q4 2021.
- A 5-year average of 58313050.0 and a median of 59228500.0 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations sank 13084.86% — and 2025, when it soared 137.99%.
- Legend Biotech's Cash from Operations stood at 198465000.0 in 2021, then jumped by 74.94% to 49742000.0 in 2022, then plunged by 92.28% to 95645000.0 in 2023, then advanced by 14.16% to 82100000.0 in 2024, then jumped by 85.14% to 12200000.0 in 2025.
- Business Quant data shows LEGN's Cash from Operations at 12200000.0 in Q4 2025, 28801000.0 in Q3 2025, and 13042000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 201.34 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.17 Mn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -12.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.20 Mn |
| Dec 31, 2025 | -12.20 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Jun 30, 2025 | -13.04 Mn |
| Jun 30, 2025 | -13.04 Mn |
| Mar 31, 2025 | -103.75 Mn |
| Mar 31, 2025 | -103.75 Mn |
| Dec 31, 2024 | -82.10 Mn |
| Dec 31, 2024 | -82.10 Mn |
| Sep 30, 2024 | -75.82 Mn |
| Sep 30, 2024 | -75.82 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Sep 30, 2023 | -60.85 Mn |
| Sep 30, 2023 | -60.85 Mn |